Mesoblast Limited Stock Market Press Releases and Company Profile
Mesoblast Limited (ASX:MSB) Update On Valeant (NYSE:VRX) Proposal To Cephalon (NASDAQ:CEPH)
Mesoblast Limited (ASX:MSB) Update On Valeant (NYSE:VRX) Proposal To Cephalon (NASDAQ:CEPH)

Melbourne, April 7, 2011 AEST (ABN Newswire) - Mesoblast Limited (googlechartASX:MSB) (googlechartPINK:MBLTY) wishes to inform the market that the Board of its strategic partner Cephalon Inc. (googlechartNASDAQ:CEPH) has rejected the unsolicited proposal from Valeant Pharmaceuticals International Inc (googlechartNYSE:VRX) to acquire its issued share capital or certain assets.

The full Cephalon response can be viewed at: http://www.cephalon.com/media/news-releases.html

Reflecting on the value of its pipeline, the Cephalon Board said it "has created one of the broadest pipelines in the industry, with 10 late-stage product candidates targeted at novel and 'best-in-class' therapeutics. This includes six indications with blockbuster potential which are projected to begin launching in the next three years."

Contact

Julie Meldrum
Corporate Communications Director
T: +61-3-9639-6036
C: +61-419-228-128
Email:julie.meldrum@mesoblast.com



ABN Newswire
ABN Newswire This Page Viewed:  (Last 7 Days: 2) (Last 30 Days: 25) (Since Published: 6819)